What Happened?
Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported disappointing fourth-quarter results: its full-year EPS and revenue guidance fell short of Wall Street's estimates. Revenue grew 5% year over year, as weakness in livestock sales, which declined due to the divestiture of certain products, was partly offset by strength in the companion animal segment. Looking ahead, Zoetis expects 6% to 8% organic operational revenue growth, but foreign exchange pressures and ongoing challenges could create headwinds. Overall, this quarter could have been better.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Zoetis? Access our full analysis report here, it’s free.
What The Market Is Telling Us
Zoetis’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. Moves this big are rare for Zoetis and indicate this news significantly impacted the market’s perception of the business.
Zoetis is down 0.4% since the beginning of the year, and at $162.02 per share, it is trading 19% below its 52-week high of $199.94 from February 2024. Investors who bought $1,000 worth of Zoetis’s shares 5 years ago would now be looking at an investment worth $1,118.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
